High expression of PMAIP1 in the subset of MYCN-amplified neuroblastomas was confirmed in a second dataset of neuroblastomas (Janoueix-Lerosey et al., 2008), again without differential expression of other key BCL-2 family members (Figure S1D). Here, BCL2 is linked to neuroblastoma.